U.S. Psoriasis Treatment MarketU.S. Psoriasis Treatment Market 2024 Trends and Forecasts 2032: Analyzing Growth Opportunities
U.S. Psoriasis Treatment Market by Drug Class (TNF Inhibitors, Interleukin Inhibitors, Others), by Type (Plaque Psoriasis, Psoriatic Arthritis, Others), by Route of Administration (Oral, Parenteral/Systemic, Topical), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), by Forecast 2024-2032
Base Year: 2023
100 Pages
U.S. Psoriasis Treatment Market 2024 Trends and Forecasts 2032: Analyzing Growth Opportunities
Key Insights:
The U.S. Psoriasis Treatment Market size was valued at USD 10.32 USD Billion in 2023 and is projected to reach USD 17.01 USD Billion by 2032, exhibiting a CAGR of 7.4 % during the forecast period. The psoriasis treatment regimen constitutes multiple treatments designed specifically for the improvement of symptoms for this incurable autoimmune condition that is defined by well-known skin inflammation and rapid cell turnover. Topicals, such as corticosteroids and vitamin D analogs, are the medicines that fight only those spots while phototherapy is the procedure that utilizes UV light to lessen the symptoms. It is the systemic medications, which contain for example methotrexate and biologics, that are for moderate to severe conditions, by suppressing the immune responses. Biotherapies as emerging treatments will trigger the change of the medicine route by virtue of their targeted mechanism and fewer side effects. Moreover, there is a major breakthrough in precision medicine, which offers individualized treatment modalities according to genetic and immunological patterns. The US market is undergoing a surge in the approval of biological drugs which, along with a lot of ongoing research aimed at improving new therapies, is clear evidence of a delightful landscape aspiring to attain better efficacy and patient outcomes.
U.S. Psoriasis Treatment Trends:
- Increasing prevalence of psoriasis and expanding awareness.
- Advancements in biological therapies and targeted treatments.
- Growing demand for long-term maintenance therapies.
Driving Forces: What's Propelling the Market:
- Rising incidence of psoriasis due to genetic and environmental factors.
- Unmet medical needs and demand for effective treatments.
- Technological advancements and ongoing research.
- Government initiatives and support for psoriasis research.
Challenges and Restraints:
- High cost of treatment and access barriers.
- Side effects and safety concerns associated with certain medications.
- Limited efficacy of existing treatments.
Emerging Trends:
- Biologic therapies and precision medicine.
- Immunosuppressive drugs and combination therapies.
- Use of artificial intelligence and machine learning in diagnosis and treatment.
Growth Catalysts:
- New drug approvals and pipeline advancements.
- Strategic collaborations and partnerships among industry players.
- Expansion into emerging markets.
Market Segmentation:
Drug Class:
- TNF Inhibitors
- Interleukin Inhibitors
- Others
Type:
- Plaque Psoriasis
- Psoriatic Arthritis
- Others
Route of Administration:
- Oral
- Parenteral/Systemic
- Topical
Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Leading Players:
- AbbVie Inc.
- Novartis AG
- Johnson & Johnson Services, Inc.
- Pfizer Inc.
- LEO Pharma A/S
- Merck & Co., Inc.
- Amgen Inc.
- Eli Lilly and Company
- Evelo Biosciences, Inc.
- UCB S.A.
- Boehringer Ingelheim International GmbH
Significant Developments:
- June 2023: Eli Lilly and Company announced the acquisition of Dice Therapeutics, Inc. for USD 2.40 billion.
- December 2021: Amgen Inc. received FDA approval for apremilast (Otezla) for plaque psoriasis.
- December 2021: AbbVie Inc. received FDA approval for RINVOQ for psoriatic arthritis.
Comprehensive Coverage:
- Market overview and industry analysis
- Market segmentation and growth trends
- Competitive landscape and key players
- Recent industry developments and future outlook
- SWOT analysis and strategic recommendations
DROCT Analysis:
- Drivers: Increasing prevalence, new drug approvals, technological advancements
- Restraints: High cost, side effects, limited efficacy
- Opportunities: Unmet medical needs, emerging markets, personalized treatments
- Challenges: Access barriers, regulatory hurdles, competition
Pricing Analysis:
- Drug pricing trends and analysis
- Impact of reimbursement policies and discounts
- Competitive pricing strategies
Patent/Trademark Analysis:
- Patent Expiration Dates and impact on Generics
- Trademark protection and brand recognition
- Intellectual property landscape
U.S. Psoriasis Treatment Market REPORT HIGHLIGHTS
| Aspects | Details |
|---|---|
| Study Period | 2018-2032 |
| Base Year | 2023 |
| Estimated Year | 2024 |
| Forecast Period | 2024-2032 |
| Historical Period | 2018-2023 |
| Growth Rate | CAGR of 7.4% from 2018-2032 |
| Segmentation |
|
Frequently Asked Questions
Table Of Content
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 2.1. Introduction
- 3. Market Dynamics
- 3.1. Introduction
- 3.2. Market Drivers
- 3.2.1. Introduction of Cost-effective Manufacturing Processes to Drive Market Growth
- 3.3. Market Restrains
- 3.3.1. Rise in Recent Product Recalls Coupled with High Treatment Cost to Impede Market Growth
- 3.4. Market Trends
- 3.4.1. Increasing Number of Hospitals and ASCs Identified as Significant Market Trend
- 4. Market Factor Analysis
- 4.1. Porters Five Forces
- 4.2. Supply/Value Chain
- 4.3. PESTEL analysis
- 4.4. Market Entropy
- 4.5. Patent/Trademark Analysis
- 5. U.S. Psoriasis Treatment Market Analysis, Insights and Forecast, 2018-2030
- 5.1. Market Analysis, Insights and Forecast - by Drug Class
- 5.1.1. TNF Inhibitors
- 5.1.2. Interleukin Inhibitors
- 5.1.3. Others
- 5.2. Market Analysis, Insights and Forecast - by Type
- 5.2.1. Plaque Psoriasis
- 5.2.2. Psoriatic Arthritis
- 5.2.3. Others
- 5.3. Market Analysis, Insights and Forecast - by Route of Administration
- 5.3.1. Oral
- 5.3.2. Parenteral/Systemic
- 5.3.3. Topical
- 5.4. Market Analysis, Insights and Forecast - by Distribution Channel
- 5.4.1. Hospital Pharmacies
- 5.4.2. Retail Pharmacies
- 5.4.3. Online Pharmacies
- 5.5. Market Analysis, Insights and Forecast - by Region
- 5.5.1.
- 5.1. Market Analysis, Insights and Forecast - by Drug Class
- 6. Northeast U.S. Psoriasis Treatment Market Analysis, Insights and Forecast, 2018-2030
- 6.1. Market Analysis, Insights and Forecast - By Drug Class
- 6.1.1 TNF Inhibitors
- 6.1.2 Interleukin Inhibitors
- 6.1.3 and Others
- 6.2. Market Analysis, Insights and Forecast - By Type
- 6.2.1 Plaque Psoriasis
- 6.2.2 Psoriatic Arthritis
- 6.2.3 and Others
- 6.3. Market Analysis, Insights and Forecast - By Route of Administration
- 6.3.1 Oral
- 6.3.2 Parenteral/Systemic
- 6.3.3 and Topical
- 6.4. Market Analysis, Insights and Forecast - By Distribution Channel
- 6.4.1 Hospital Pharmacies
- 6.4.2 Retail Pharmacies
- 6.4.3 and Online Pharmacies
- 7. Southeast U.S. Psoriasis Treatment Market Analysis, Insights and Forecast, 2018-2030
- 7.1. Market Analysis, Insights and Forecast - By Drug Class
- 7.1.1 TNF Inhibitors
- 7.1.2 Interleukin Inhibitors
- 7.1.3 and Others
- 7.2. Market Analysis, Insights and Forecast - By Type
- 7.2.1 Plaque Psoriasis
- 7.2.2 Psoriatic Arthritis
- 7.2.3 and Others
- 7.3. Market Analysis, Insights and Forecast - By Route of Administration
- 7.3.1 Oral
- 7.3.2 Parenteral/Systemic
- 7.3.3 and Topical
- 7.4. Market Analysis, Insights and Forecast - By Distribution Channel
- 7.4.1 Hospital Pharmacies
- 7.4.2 Retail Pharmacies
- 7.4.3 and Online Pharmacies
- 8. Midwest U.S. Psoriasis Treatment Market Analysis, Insights and Forecast, 2018-2030
- 8.1. Market Analysis, Insights and Forecast - By Drug Class
- 8.1.1 TNF Inhibitors
- 8.1.2 Interleukin Inhibitors
- 8.1.3 and Others
- 8.2. Market Analysis, Insights and Forecast - By Type
- 8.2.1 Plaque Psoriasis
- 8.2.2 Psoriatic Arthritis
- 8.2.3 and Others
- 8.3. Market Analysis, Insights and Forecast - By Route of Administration
- 8.3.1 Oral
- 8.3.2 Parenteral/Systemic
- 8.3.3 and Topical
- 8.4. Market Analysis, Insights and Forecast - By Distribution Channel
- 8.4.1 Hospital Pharmacies
- 8.4.2 Retail Pharmacies
- 8.4.3 and Online Pharmacies
- 9. Southwest U.S. Psoriasis Treatment Market Analysis, Insights and Forecast, 2018-2030
- 9.1. Market Analysis, Insights and Forecast - By Drug Class
- 9.1.1 TNF Inhibitors
- 9.1.2 Interleukin Inhibitors
- 9.1.3 and Others
- 9.2. Market Analysis, Insights and Forecast - By Type
- 9.2.1 Plaque Psoriasis
- 9.2.2 Psoriatic Arthritis
- 9.2.3 and Others
- 9.3. Market Analysis, Insights and Forecast - By Route of Administration
- 9.3.1 Oral
- 9.3.2 Parenteral/Systemic
- 9.3.3 and Topical
- 9.4. Market Analysis, Insights and Forecast - By Distribution Channel
- 9.4.1 Hospital Pharmacies
- 9.4.2 Retail Pharmacies
- 9.4.3 and Online Pharmacies
- 10. West U.S. Psoriasis Treatment Market Analysis, Insights and Forecast, 2018-2030
- 10.1. Market Analysis, Insights and Forecast - By Drug Class
- 10.1.1 TNF Inhibitors
- 10.1.2 Interleukin Inhibitors
- 10.1.3 and Others
- 10.2. Market Analysis, Insights and Forecast - By Type
- 10.2.1 Plaque Psoriasis
- 10.2.2 Psoriatic Arthritis
- 10.2.3 and Others
- 10.3. Market Analysis, Insights and Forecast - By Route of Administration
- 10.3.1 Oral
- 10.3.2 Parenteral/Systemic
- 10.3.3 and Topical
- 10.4. Market Analysis, Insights and Forecast - By Distribution Channel
- 10.4.1 Hospital Pharmacies
- 10.4.2 Retail Pharmacies
- 10.4.3 and Online Pharmacies
- 11. Competitive Analysis
- 11.1. Market Share Analysis 2023
- 11.2. Company Profiles
- 11.2.1 AbbVie Inc. (U.S.)
- 11.2.1.1. Overview
- 11.2.1.2. Products
- 11.2.1.3. SWOT Analysis
- 11.2.1.4. Recent Developments
- 11.2.1.5. Financials (Based on Availability)
- 11.2.2 Novartis AG (Switzerland)
- 11.2.2.1. Overview
- 11.2.2.2. Products
- 11.2.2.3. SWOT Analysis
- 11.2.2.4. Recent Developments
- 11.2.2.5. Financials (Based on Availability)
- 11.2.3 Johnson & Johnson Services Inc.(U.S.)
- 11.2.3.1. Overview
- 11.2.3.2. Products
- 11.2.3.3. SWOT Analysis
- 11.2.3.4. Recent Developments
- 11.2.3.5. Financials (Based on Availability)
- 11.2.4 Pfizer Inc. (U.S.)
- 11.2.4.1. Overview
- 11.2.4.2. Products
- 11.2.4.3. SWOT Analysis
- 11.2.4.4. Recent Developments
- 11.2.4.5. Financials (Based on Availability)
- 11.2.5 LEO Pharma A/S (Denmark)
- 11.2.5.1. Overview
- 11.2.5.2. Products
- 11.2.5.3. SWOT Analysis
- 11.2.5.4. Recent Developments
- 11.2.5.5. Financials (Based on Availability)
- 11.2.6 Merck & Co. Inc. (U.S.)
- 11.2.6.1. Overview
- 11.2.6.2. Products
- 11.2.6.3. SWOT Analysis
- 11.2.6.4. Recent Developments
- 11.2.6.5. Financials (Based on Availability)
- 11.2.7 Amgen Inc. (U.S.)
- 11.2.7.1. Overview
- 11.2.7.2. Products
- 11.2.7.3. SWOT Analysis
- 11.2.7.4. Recent Developments
- 11.2.7.5. Financials (Based on Availability)
- 11.2.8 Eli Lilly and Company (U.S.)
- 11.2.8.1. Overview
- 11.2.8.2. Products
- 11.2.8.3. SWOT Analysis
- 11.2.8.4. Recent Developments
- 11.2.8.5. Financials (Based on Availability)
- 11.2.9 Evelo Biosciences Inc. (U.S.)
- 11.2.9.1. Overview
- 11.2.9.2. Products
- 11.2.9.3. SWOT Analysis
- 11.2.9.4. Recent Developments
- 11.2.9.5. Financials (Based on Availability)
- 11.2.10 UCB S.A. (Belgium)
- 11.2.10.1. Overview
- 11.2.10.2. Products
- 11.2.10.3. SWOT Analysis
- 11.2.10.4. Recent Developments
- 11.2.10.5. Financials (Based on Availability)
- 11.2.11 Boehringer Ingelheim International GmbH (Germany)
- 11.2.11.1. Overview
- 11.2.11.2. Products
- 11.2.11.3. SWOT Analysis
- 11.2.11.4. Recent Developments
- 11.2.11.5. Financials (Based on Availability)
- 11.2.1 AbbVie Inc. (U.S.)
List of Figures
- Figure 1: U.S. Psoriasis Treatment Market Revenue Breakdown (USD Billion, %) by Product 2023 & 2031
- Figure 2: U.S. Psoriasis Treatment Market Value Share (%), by Drug Class 2023 & 2031
- Figure 3: U.S. Psoriasis Treatment Market Value Share (%), by Type 2023 & 2031
- Figure 4: U.S. Psoriasis Treatment Market Value Share (%), by Route of Administration 2023 & 2031
- Figure 5: U.S. Psoriasis Treatment Market Value Share (%), by Distribution Channel 2023 & 2031
- Figure 6: U.S. Psoriasis Treatment Market Share (%) by Company 2023
List of Tables
- Table 1: U.S. Psoriasis Treatment Market Revenue USD Billion Forecast, by Drug Class 2018 & 2031
- Table 2: U.S. Psoriasis Treatment Market Revenue USD Billion Forecast, by Type 2018 & 2031
- Table 3: U.S. Psoriasis Treatment Market Revenue USD Billion Forecast, by Route of Administration 2018 & 2031
- Table 4: U.S. Psoriasis Treatment Market Revenue USD Billion Forecast, by Distribution Channel 2018 & 2031
- Table 5: U.S. Psoriasis Treatment Market Revenue USD Billion Forecast, by Region 2018 & 2031
- Table 6: U.S. Psoriasis Treatment Market Revenue USD Billion Forecast, by Drug Class 2018 & 2031
- Table 7: U.S. Psoriasis Treatment Market Revenue USD Billion Forecast, by Type 2018 & 2031
- Table 8: U.S. Psoriasis Treatment Market Revenue USD Billion Forecast, by Route of Administration 2018 & 2031
- Table 9: U.S. Psoriasis Treatment Market Revenue USD Billion Forecast, by Distribution Channel 2018 & 2031
- Table 10: U.S. Psoriasis Treatment Market Revenue USD Billion Forecast, by Region 2018 & 2031
- Table 11: U.S. Psoriasis Treatment Market Revenue USD Billion Forecast, by Drug Class 2018 & 2031
- Table 12: U.S. Psoriasis Treatment Market Revenue USD Billion Forecast, by Type 2018 & 2031
- Table 13: U.S. Psoriasis Treatment Market Revenue USD Billion Forecast, by Route of Administration 2018 & 2031
- Table 14: U.S. Psoriasis Treatment Market Revenue USD Billion Forecast, by Distribution Channel 2018 & 2031
- Table 15: U.S. Psoriasis Treatment Market Revenue USD Billion Forecast, by Country 2018 & 2031
- Table 16: Northeast U.S. Psoriasis Treatment Market Revenue (USD Billion) Forecast, by Application 2018 & 2031
- Table 17: Southeast U.S. Psoriasis Treatment Market Revenue (USD Billion) Forecast, by Application 2018 & 2031
- Table 18: Midwest U.S. Psoriasis Treatment Market Revenue (USD Billion) Forecast, by Application 2018 & 2031
- Table 19: Southwest U.S. Psoriasis Treatment Market Revenue (USD Billion) Forecast, by Application 2018 & 2031
- Table 20: West U.S. Psoriasis Treatment Market Revenue (USD Billion) Forecast, by Application 2018 & 2031
- Table 21: U.S. Psoriasis Treatment Market Revenue USD Billion Forecast, by Drug Class 2018 & 2031
- Table 22: U.S. Psoriasis Treatment Market Revenue USD Billion Forecast, by Type 2018 & 2031
- Table 23: U.S. Psoriasis Treatment Market Revenue USD Billion Forecast, by Route of Administration 2018 & 2031
- Table 24: U.S. Psoriasis Treatment Market Revenue USD Billion Forecast, by Distribution Channel 2018 & 2031
- Table 25: U.S. Psoriasis Treatment Market Revenue USD Billion Forecast, by Country 2018 & 2031
| Aspects | Details |
|---|---|
| Study Period | 2018-2032 |
| Base Year | 2023 |
| Estimated Year | 2024 |
| Forecast Period | 2024-2032 |
| Historical Period | 2018-2023 |
| Growth Rate | CAGR of 7.4% from 2018-2032 |
| Segmentation |
|
STEP 1 - Identification of Relevant Samples Size from Population Database
STEP 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)
Top-down and bottom-up approaches are used to validate the global market size and estimate the market size for manufactures, regional segemnts, product and application.
Note* : In applicable scenarios
STEP 3 - Data Sources
Primary Research
- Web Analytics
- Survey Reports
- Research Institute
- Latest Research Reports
- Opinion Leaders
Secondary Research
- Annual Reports
- White Paper
- Latest Press Release
- Industry Association
- Paid Database
- Investor Presentations
STEP 4 - Data Triangulation
Involves using different sources of information in order to increase the validity of a study
These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.
Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.
During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence
Additionally after gathering mix and scattered data from wide range of sources, data is triangull- ated and correlated to come up with estimated figures which are further validated through primary mediums, or industry experts, opinion leader.
About Market Research Forecast
MR Forecast provides premium market intelligence on deep technologies that can cause a high level of disruption in the market within the next few years. When it comes to doing market viability analyses for technologies at very early phases of development, MR Forecast is second to none. What sets us apart is our set of market estimates based on secondary research data, which in turn gets validated through primary research by key companies in the target market and other stakeholders. It only covers technologies pertaining to Healthcare, IT, big data analysis, block chain technology, Artificial Intelligence (AI), Machine Learning (ML), Internet of Things (IoT), Energy & Power, Automobile, Agriculture, Electronics, Chemical & Materials, Machinery & Equipment's, Consumer Goods, and many others at MR Forecast. Market: The market section introduces the industry to readers, including an overview, business dynamics, competitive benchmarking, and firms' profiles. This enables readers to make decisions on market entry, expansion, and exit in certain nations, regions, or worldwide. Application: We give painstaking attention to the study of every product and technology, along with its use case and user categories, under our research solutions. From here on, the process delivers accurate market estimates and forecasts apart from the best and most meaningful insights.
Products generically come under this phrase and may imply any number of goods, components, materials, technology, or any combination thereof. Any business that wants to push an innovative agenda needs data on product definitions, pricing analysis, benchmarking and roadmaps on technology, demand analysis, and patents. Our research papers contain all that and much more in a depth that makes them incredibly actionable. Products broadly encompass a wide range of goods, components, materials, technologies, or any combination thereof. For businesses aiming to advance an innovative agenda, access to comprehensive data on product definitions, pricing analysis, benchmarking, technological roadmaps, demand analysis, and patents is essential. Our research papers provide in-depth insights into these areas and more, equipping organizations with actionable information that can drive strategic decision-making and enhance competitive positioning in the market.
